A simple, powerful idea is reshaping medicine: No one knows better than patients and their caregivers what patients want and need. Patient preferences are especially powerful when decisions involve trade-offs between benefits and risks.
Dr. Karl Deisseroth has pioneered technologies for studying the brain that are changing the way neuroscientists think about anxiety, addiction, depression and other disorders.
Meet four FDA reviewers who are determining the future of care for patients suffering from blood, breast, lung or ovarian cancer.
Dr. Richard Pazdur is the world's most important cancer drug regulator
NIH Director Dr. Francis Collins sang about optogenetics and CLARITY brain imaging at the Foundation for NIH Lurie Awards ceremony.